NLRP3 and endometriosis: Overactive estrogen receptors diminish HDL function and elevate TG and NHHR, which then activate the NLRP3 inflammasome and drive excessive IL-1β release, sustaining lesion growth and underscoring the pivotal role of the lipid–inflammation axis in endometriosis.